Lancet Infect Dis. 2019 Apr;19(4):369-381. doi: 10.1016/S1473-3099(18)30685-6. Epub 2019 Feb 18.
Efforts to quantify the global burden of enteric fever are valuable for understanding the health lost and the large-scale spatial distribution of the disease. We present the estimates of typhoid and paratyphoid fever burden from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, and the approach taken to produce them.
For this systematic analysis we broke down the relative contributions of typhoid and paratyphoid fevers by country, year, and age, and analysed trends in incidence and mortality. We modelled the combined incidence of typhoid and paratyphoid fevers and split these total cases proportionally between typhoid and paratyphoid fevers using aetiological proportion models. We estimated deaths using vital registration data for countries with sufficiently high data completeness and using a natural history approach for other locations. We also estimated disability-adjusted life-years (DALYs) for typhoid and paratyphoid fevers.
Globally, 14·3 million (95% uncertainty interval [UI] 12·5-16·3) cases of typhoid and paratyphoid fevers occurred in 2017, a 44·6% (42·2-47·0) decline from 25·9 million (22·0-29·9) in 1990. Age-standardised incidence rates declined by 54·9% (53·4-56·5), from 439·2 (376·7-507·7) per 100 000 person-years in 1990, to 197·8 (172·0-226·2) per 100 000 person-years in 2017. In 2017, Salmonella enterica serotype Typhi caused 76·3% (71·8-80·5) of cases of enteric fever. We estimated a global case fatality of 0·95% (0·54-1·53) in 2017, with higher case fatality estimates among children and older adults, and among those living in lower-income countries. We therefore estimated 135·9 thousand (76·9-218·9) deaths from typhoid and paratyphoid fever globally in 2017, a 41·0% (33·6-48·3) decline from 230·5 thousand (131·2-372·6) in 1990. Overall, typhoid and paratyphoid fevers were responsible for 9·8 million (5·6-15·8) DALYs in 2017, down 43·0% (35·5-50·6) from 17·2 million (9·9-27·8) DALYs in 1990.
Despite notable progress, typhoid and paratyphoid fevers remain major causes of disability and death, with billions of people likely to be exposed to the pathogens. Although improvements in water and sanitation remain essential, increased vaccine use (including with typhoid conjugate vaccines that are effective in infants and young children and protective for longer periods) and improved data and surveillance to inform vaccine rollout are likely to drive the greatest improvements in the global burden of the disease.
Bill & Melinda Gates Foundation.
量化肠热病(伤寒和副伤寒)的全球负担对于了解疾病造成的健康损失和疾病的大规模空间分布具有重要意义。我们展示了全球疾病、伤害和风险因素研究(GBD)2017 年对伤寒和副伤寒负担的估计,以及产生这些估计的方法。
在这项系统分析中,我们按国家、年份和年龄细分了伤寒和副伤寒的相对贡献,并分析了发病率和死亡率的趋势。我们通过病因比例模型对伤寒和副伤寒的合并发病率进行建模,并将这些总病例按比例分配给伤寒和副伤寒。我们使用有足够高数据完整性的国家的生命登记数据来估计死亡人数,而对于其他地点则使用自然史方法。我们还估计了伤寒和副伤寒的残疾调整生命年(DALY)。
全球 2017 年有 1430 万例(95%置信区间 [UI] 1250-1630)伤寒和副伤寒病例,比 1990 年的 2590 万例(2200-2990)下降了 44.6%(42.2-47.0)。标准化发病率下降了 54.9%(53.4-56.5),从 1990 年的每 10 万人 439.2 例(376.7-507.7)降至 2017 年的每 10 万人 197.8 例(172.0-226.2)。2017 年,肠沙门氏菌血清型 Typhi 引起了 76.3%(71.8-80.5)的肠热病病例。我们估计 2017 年全球伤寒和副伤寒的病死率为 0.95%(0.54-1.53),儿童和老年人以及生活在低收入国家的人群病死率更高。因此,我们估计 2017 年全球有 13.59 万例(7.69-21.89)伤寒和副伤寒死亡,比 1990 年的 23.05 万例(13.12-37.26)下降了 41.0%(33.6-48.3)。总的来说,2017 年伤寒和副伤寒导致 980 万(560-1580)残疾调整生命年(DALY),比 1990 年的 1720 万(990-2780)下降了 43.0%(35.5-50.6)。
尽管取得了显著进展,但伤寒和副伤寒仍是导致残疾和死亡的主要原因,数十亿人可能接触到这些病原体。尽管改善水和卫生条件仍然至关重要,但增加疫苗使用(包括对婴儿和幼儿有效且保护期更长的伤寒结合疫苗)以及改进数据和监测以指导疫苗推出,可能会使疾病的全球负担得到最大程度的改善。
比尔及梅琳达·盖茨基金会。